Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study.
COVID-19
health policy
mental health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
05 07 2021
05 07 2021
Historique:
entrez:
6
7
2021
pubmed:
7
7
2021
medline:
10
7
2021
Statut:
epublish
Résumé
To investigate the factors associated with serious psychological distress (SPD) during the COVID-19 pandemic in Japan. Nationwide cross-sectional study using survey data. Internet survey using sampling weights for national estimates conducted between 25 August and 30 September 2020 in Japan. Demographics (age, gender), socioeconomic status (income level, employment type, educational attainment, marital status, family composition and caregiving burden); the experience of domestic violence (DV), the state of emergency and fear of and stigma related to COVID-19. Prevalence of SPD, defined as Kessler 6 Scale score ≥13. Among 25 482 respondents, 10.0% met the criteria of SPD. Overall, women (adjusted OR (aOR) 1.59; 95% CI 1.17 to 2.16; p=0.003), ages 15-29 (aOR 2.35 compared with ages 45-59 years; 95% CI 1.64 to 3.38; p<0.001), low-income level (aOR 1.70 compared with intermediate income; 95% CI 1.16 to 2.49; p=0.007), providing caregiving to family members (aOR 5.48; 95% CI 3.51 to 8.56; p<0.001), experiencing DV (aOR 5.72; 95% CI 3.81 to 8.59; p<0.001) and fear of COVID-19 (aOR 1.96; 95% CI 1.55 to 2.48; p<0.001) were associated with SPD. Among women aged 15-29 years, who have a higher risk of suicide during the COVID-19 pandemic in Japan, caregiving, DV, fear of COVID-19 and COVID-19-related stigma were associated with SPD. Economic situation, caregiving burden, DV and fear of COVID-19 were independently associated with SPD during the COVID-19 pandemic. Among young women, similar factors, except economic situation, were associated with SPD. Targeted interventions based on age and gender may be more effective in mitigating the negative impact of the COVID-19 pandemic on the population's mental health.
Identifiants
pubmed: 34226236
pii: bmjopen-2021-051115
doi: 10.1136/bmjopen-2021-051115
pmc: PMC8260284
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e051115Subventions
Organisme : NIA NIH HHS
ID : R01 AG068633
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD013913
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: TT was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants (grant number 18H03062). YT was supported by the National Institutes of Health (NIH)/NIMHD Grant R01MD013913 and NIH/NIA Grant R01AG068633 for other work not related to this study.
Références
Tob Control. 2018 Jul;27(e1):e25-e33
pubmed: 29248896
BMC Pregnancy Childbirth. 2020 Nov 18;20(1):703
pubmed: 33208115
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
JAMA. 2019 Aug 27;322(8):756-763
pubmed: 31454044
Psychol Trauma. 2020 Aug;12(S1):S17-S21
pubmed: 32496100
JAMA Netw Open. 2020 Oct 1;3(10):e2026064
pubmed: 33104209
Am Psychol. 2020 Jul-Aug;75(5):631-643
pubmed: 32437181
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
Curr Psychiatry Rep. 2019 Feb 7;21(2):10
pubmed: 30729322
Lancet Psychiatry. 2020 May;7(5):389-390
pubmed: 32353269
J Clin Epidemiol. 2012 Sep;65(9):970-7
pubmed: 22742911
Eur J Public Health. 2019 Feb 1;29(1):147-153
pubmed: 30084947
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Nat Hum Behav. 2021 Feb;5(2):229-238
pubmed: 33452498
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
Transl Psychiatry. 2019 Jan 31;9(1):52
pubmed: 30705256
Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):311-7
pubmed: 21762826
BMC Public Health. 2021 Jan 7;21(1):79
pubmed: 33413224
BMJ Open. 2021 May 13;11(5):e049851
pubmed: 33986068
Am J Crim Justice. 2020 Jun 14;:1-35
pubmed: 32837161
Int J Environ Res Public Health. 2020 Dec 15;17(24):
pubmed: 33333893
PLoS One. 2020 Dec 28;15(12):e0244630
pubmed: 33370404
Lancet Psychiatry. 2020 Jun;7(6):468-471
pubmed: 32330430
Brain Behav. 2020 Nov;10(11):e01818
pubmed: 32869541
JAMA Netw Open. 2021 Feb 1;4(2):e2037378
pubmed: 33528554
R Soc Open Sci. 2021 Feb 10;8(2):200589
pubmed: 33972837
Int J Epidemiol. 2005 Apr;34(2):286-93
pubmed: 15561750
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
Gen Hosp Psychiatry. 2021 Jul-Aug;71:88-94
pubmed: 33971518
Int J Ment Health Addict. 2020 Jul 13;:1-11
pubmed: 32837445
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Sci Rep. 2021 May 13;11(1):10173
pubmed: 33986414
Psychiatry Clin Neurosci. 2020 Oct;74(10):566-568
pubmed: 32779787
J Epidemiol. 2020 Nov 5;30(11):522-528
pubmed: 32963212
N Engl J Med. 2020 Oct 8;383(15):1483-1488
pubmed: 32706956
JAMA Psychiatry. 2019 Feb 1;76(2):152-161
pubmed: 30484838
J Affect Disord. 2021 Mar 1;282:707-711
pubmed: 33445097
J Psychosom Obstet Gynaecol. 2020 Sep;41(3):183-190
pubmed: 32379999
Allergy. 2020 Nov;75(11):2829-2845
pubmed: 32496587
J Epidemiol. 2019 Nov 5;29(11):444-450
pubmed: 30318495
J Occup Environ Hyg. 2021 Apr-May;18(4-5):169-179
pubmed: 33861938
Am J Obstet Gynecol. 2020 Aug;223(2):240.e1-240.e9
pubmed: 32437665
Int J Environ Res Public Health. 2021 Apr 02;18(7):
pubmed: 33918378
Lancet Public Health. 2020 Jun;5(6):e309
pubmed: 32401709
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Ageing Res Rev. 2021 Jan;65:101205
pubmed: 33137510
Psychiatry Res. 2020 Nov;293:113486
pubmed: 33007682
Soc Sci Med. 2020 Dec;266:113425
pubmed: 33059301